Sarepta Up 12% As FDA Is 'Actively Engaged' On Drug Application By: Benzinga via Benzinga July 30, 2014 at 11:33 AM EDT Sarepta Therapeutics (NASDAQ: SRPT) opened sharply higher after the Food and Drug Administration made favorable noises about the ... Read More >> Related Stocks: Sarepta Therapeutics Starwood Hotels & Resorts